The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient (pt) characteristics, treatment patterns, outcomes and prognostic factors in plasmacytoid urothelial carcinoma (PUC).
 
Leonidas Nikolaos Diamantopoulos
No Relationships to Disclose
 
Ali Raza Khaki
Stock and Other Ownership Interests - Pfizer; Procter & Gamble; Walgreens Boots Alliance
 
Funda Vakar-Lopez
Patents, Royalties, Other Intellectual Property - Bloodworks Northwest (I)
 
Maria S. Tretiakova
No Relationships to Disclose
 
John L. Gore
No Relationships to Disclose
 
George R Schade
Patents, Royalties, Other Intellectual Property - Global Cancer Technology
 
Sarah P. Psutka
Honoraria - Prime Education
Travel, Accommodations, Expenses - Prime Education
 
Andrew Caleb Hsieh
Honoraria - Hotspot Therapeutics
Research Funding - eFFECTOR Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
John Kyung Lee
Research Funding - Immunomedics
 
Todd Yezefski
No Relationships to Disclose
 
Michael Thomas Schweizer
Consulting or Advisory Role - Janssen
Research Funding - AstraZeneca (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)
 
Heather H. Cheng
Research Funding - Astellas Medivation (Inst); Clovis Oncology (Inst); Color Genomics Foundation (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Sanofi (Inst)
 
Evan Y. Yu
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Churchill Pharmaceuticals; Dendreon; EMD Serono; Incyte; Janssen; Merck; QED Therapeutics; Seagen; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen (Inst)
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Foundation Medicine; Genentech; HERON; Janssen; Merck; Pfizer; QED Therapeutics; Seagen
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Robert B. Montgomery
Research Funding - AstraZeneca; ESSA; Ferring; Janssen Oncology
 
Jonathan L. Wright
Speakers' Bureau - Foundation Health Partners J. Michael Carroll Cancer Center; OncLive; seattle cancer care alliance
Research Funding - Altor BioScience; Merck; Nucleix
Other Relationship - Movember Foundation; UpToDate